Skip to content
Open access

Evaluation of Risk Factors in Patients with Triple Negative Breast Cancer in a Tertiary Hospital

Jul 2026 · Journal of surgical sciences · Vol 29, pp. 24-29 · 0 citations · 36 references

TL;DR

Family history of breast cancer, gene mutation and moderate physical activity are found significant as risk factors for TNBC.

Abstract

Introduction: Triple Negative Breast Cancer (TNBC) is known to have high recurrence, poor prognosis and has limited treatment options. This study was designed to evaluate the risk factors associated with patients with breast cancer. Methods: This cross-sectional study was conducted in the Department of General Surgery, Bangabandhu Sheikh Mujib Medical University (BSMMU) from January 2023 to December 2023 where 116 patients were analyzed which included 58 diagnosed cases of TNBC and 58 non-TNBC cases. Both non-modifiable and modifiable risk factors were recorded. Result: Non-modifiable risk factors, such as family history of breast cancer (22.41% vs. 0%) were significantly associated with TNBC patients while there was no history of family history of breast cancer among non-TNBC respondents. Among TNBC respondents who had the family history of breast cancer underwent gene amplification test and results showed that 84.6% had BRCA1/BRCA2 gene mutation. Other non-modifiable risk factors such as early menarche and early menopause were not significantly associated with TNBC. Modifiable risk factor, such as moderate intensity physical activity had shown significant risk for TNBC (96.6% and 82.8%). However, only 6.9% TNBC respondents had obesity while 17.2% were obese in non TNBC respondents and 62.1% had history of OCP in TNBC while 48.3% respondents had history of OCP in non TNBC patients. No respondents had history of smoking and alcohol. Conclusion: Family history of breast cancer, gene mutation and moderate physical activity are found significant as risk factors for TNBC. Journal of Surgical Sciences 2025;29(1): 24-29

Read PDF

Similar papers

Influence of a family history of breast and/or ovarian cancer on breast cancer outcomes

The results found that women diagnosed with FBC had an early onset of disease in the population studied, and the poor outcome of patients with a family history of BOC associated with survival was restricted to the hormone receptor-positive population.

A. Cao, Min He, G. Di et al. · 0 citations
Open access Aug 2026

Predictors of Breast Cancer Development Following Surgery for Benign Breast Diseases

Surgical trauma is not an independent etiological factor in the development of breast cancer; however, its combination with endogenous factors promotes carcinogenesis.

V. Dronenko, O. Kostiuk, S. A. Lysenko et al. · 0 citations
Open access Aug 2026

Family history of cancer and risk of lung cancer: a retrospective cohort study in a Chinese population

In this selected cohort of patients evaluated for pulmonary nodules, family history was not positively associated with malignancy, and the inverse adjusted associations are most plausibly explained by referral- and surveillance-related selection rather than biological protection.

Hong-Jun Song, Xin-Lu Men, Jun Cheng et al. · 0 citations
Open access Aug 2026

Clinicopathological features, etiological factors and survival outcomes in breast cancer treated with neoadjuvant chemotherapy: a study from western Algeria

Breast cancer is the most frequently diagnosed malignancy and the leading cause of cancer-related death among women. It is a biologically heterogeneous disease resulting from a multifactorial process. Neoadjuvant chemotherapy (NACT) has become a key treatment for patients with locally advanced or high-risk early-stage...

Olfa Aissa, Aicha Rabah, A. Bousahba et al. · 0 citations
Open access Sep 2026

Diagnostic and Prognostic Aspects of Breast Cancer in Young Women at the Thiès Regional Hospital Center, Senegal

Breast cancer is increasingly prevalent among young women and presents with a more aggressive profile and a poorer prognosis than in older women and management remains challenging and may be complicated by diagnostic delays, poor therapeutic adherence, and a persistently low survival rate.

K. Fall, L. Gueye, N. Faye et al. · 0 citations
Aug 2026

Cardiovascular disease in breast cancer patients receiving chemotherapy: epidemiology and risk factors

Evaluating the occurrence of new-onset CVD in women with breast cancer undergoing chemotherapy and identifying factors associated with increased risk of cardiovascular disease highlights the need for sustained cardiovascular surveillance in breast cancer survivors.

V. Dvorovy, L. Kováčová, M. Selvek et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.